Prescription drug · ANDA
Valproic Acid NDC 17856-0152
Valproic acid 250 mg/1 · Capsule, Liquid filled · Oral · ATLANTIC BIOLOGICALS CORP.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17856-0152-1 | 17856015201 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-0152-1) / 1 CAPSULE, LIQUID FILLED in 1 POUCHMarketed from Jun 25, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Valproic Acid
- Generic name (nonproprietary)
- valproic acid
- Active ingredients
- Valproic acid — 250 mg/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 073484
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 17856-0152_38930d1f-1f70-1fa5-e063-6394a90a5c21SPL ID 38930d1f-1f70-1fa5-e063-6394a90a5c21SPL set ID 453444b6-1f50-49de-ab3c-1e429c83bffaRxCUI 1099681UNII 614OI1Z5WI
- Pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N417856015201followed by a unit qualifier and the quantityPackage 17856-0152-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Valproic Acid Capsules are indicated for: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1 ) 1.1 Epilepsy Valproic Acid Capsules are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic Acid Capsules are indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include a…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 073484
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8205 |
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-279 |
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | Bionpharma Inc. | 69452-150 |
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | Bryant Ranch Prepack | 63629-2454 |
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | REMEDYREPACK INC. | 70518-0079 |